eMDI connected metered-dose inhaler

H&T Presspart will be attending and speaking at this years Med-Tech Innovation show which will take place at the NEC Birmingham, UK from 29-30 September. During the show H&T Presspart’s speech will be delivering a talk on the Health-Tech stage entitled “The Future Of Connected Asthma And COPD Care: A Stepwise Development”.

 

Med-Tech Innovation Expo is the UK & Ireland’s leading event for medical design and manufacturing technology and is home to over 5,000 attendees and 300 exhibitors as well as engineers, innovators and manufacturers from across the medical and healthcare sector.

H&T Presspart’s program manager Kyle Wilson will be conducting the speech on connected devices. In this function, he is responsible for this innovative product segment, which includes H&T Presspart’s eMDI, the first market-ready, fully embedded and connected metered-dose inhaler. He oversees implementation of the platform technology basis in adjacent applications for products such as DPIs and/or customer specific developments. Kyle has an MBA from Handelshochschule Leipzig and Bachelor of Science in Mechanical Engineering from Purdue University. He joined H&T Presspart in 2015, starting as a project manager and later as Program Manager for mechanical dose counters for actuators prior to taking on his current role.

Kyle and the rest of the team look forward to seeing you in September. If you have any further questions or would like to arrange a meeting during the show, please contact us.